We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BARDA Director Contests ‘Involuntary’ Transfer to Diagnostics Role
BARDA Director Contests ‘Involuntary’ Transfer to Diagnostics Role
Rick Bright, the ex-director of HHS’s Biomedical Advanced Research and Development Authority (BARDA), said that he was removed from his post because he pushed back against the administration’s promotion of two anti-malaria drugs to treat COVID-19.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor